Literature DB >> 24630382

Risk factors and incidence of stroke and MACE in Chinese atrial fibrillation patients presenting to emergency departments: a national wide database analysis.

Yan-Min Yang1, Xing-Hui Shao1, Jun Zhu2, Han Zhang1, Yao Liu1, Xin Gao1, Li-Sheng Liu1, Li-Tian Yu1, Li Zhao3, Peng-Fei Yu4, Hua Zhang5, Qing He6, Xiao-Dan Gu7.   

Abstract

BACKGROUND: Contemporary clinical risk stratification schemata for predicting stroke and thromboembolism in patients with atrial fibrillation (AF) are largely derived from western cohorts. The purpose of the present study is to assess the potential risk factors for stroke and major adverse cardiac events (MACE) in a large population of Chinese AF patients presenting to emergency department.
METHODS: The Chinese AF registry is a multicenter, prospective, observational study with 1 year follow up. Patients who presented to an emergency department with atrial fibrillation or atrial flutter were recruited from November 2008 to October 2011. The MACE included all cause mortality, stroke, non-central nervous system systemic embolism and major bleed.
RESULTS: A total of 2016 AF patients (1104 women) were included in the final analysis. Multivariate Cox regression analysis showed that the risk factors for stroke were female gender (1.419 (1.003-2.008), p=0.048), age ≥ 75 (2.576 (1.111-4.268), p<0.001), previous stroke/TIA (2.039 (1.415-2.939), p<0.001), LVSD (1.700 (1.015-2.848), p=0.044) and previous major bleeding (2.481 (1.141-5.397), p=0.022). For MACE, age ≥ 75 (3.042 (2.274-4.071), p<0.001), heart failure (1.371 (1.088-1.728), p=0.008), previous stroke/TIA (1.560 (1.244-1.957), p<0.001), LVSD (1.424 (1.089-1.862), p=0.010) and COPD (1.393 (1.080-1.798), p=0.011) were independent risk factors. History of hypertension and diabetes was not associated with the events, neither stroke nor MACE. For non-anticoagulation patients, the c-statistic for predicting stroke was 0.685 (0.637-0.732) and for MACE was 0.717 (0.687-0.746), respectively.
CONCLUSIONS: We demonstrated that, except for the traditional risk factors, clinicians should pay more attention to patients with prior major bleeding or COPD in Chinese AF patients presenting to emergency department.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; MACE (major adverse cardiac events); Risk factors; Stroke

Mesh:

Substances:

Year:  2014        PMID: 24630382     DOI: 10.1016/j.ijcard.2014.02.040

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

Review 1.  Use of P wave indices to evaluate efficacy of catheter ablation and atrial fibrillation recurrence: a systematic review and meta-analysis.

Authors:  Peng Liu; Tingting Lv; Ying Yang; Qinggele Gao; Ping Zhang
Journal:  J Interv Card Electrophysiol       Date:  2022-04-30       Impact factor: 1.900

2.  Rationale and design of a prospective, multicenter, cross-sectional study of appropriateness evaluation of the prescription of non-vitamin K antagonist oral anticoagulants for Chinese atrial fibrillation patients (Chi-NOACs-AF trial).

Authors:  Zheng Ding; Chi Zhang; Yi-Yi Qian; Na Wang; Zhi-Chun Gu; Hang Xu; Ying-Li Zheng
Journal:  Ann Transl Med       Date:  2021-04

3.  The progression in atrial fibrillation patients with COPD: a systematic review and meta-analysis.

Authors:  Xiaoying Chen; Meiling Lin; Wei Wang
Journal:  Oncotarget       Date:  2017-10-26

4.  Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study.

Authors:  Yutao Guo; Yutang Wang; Xiaoying Li; Zaoliang Shan; Xiangmin Shi; Guorong Xi; Gregory Y H Lip
Journal:  BMJ Open       Date:  2018-05-05       Impact factor: 2.692

5.  The Burden of Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases: A Non-Western Perspective.

Authors:  Kartik Deshmukh; Arjun Khanna
Journal:  Tuberc Respir Dis (Seoul)       Date:  2021-02-17

6.  Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry.

Authors:  Yasuhiro Hamatani; Yugo Yamashita; Masahiro Esato; Yeong-Hwa Chun; Hikari Tsuji; Hiromichi Wada; Koji Hasegawa; Mitsuru Abe; Gregory Y H Lip; Masaharu Akao
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.